We Offer Worldwide Shipping
Login Wishlist

Gossypin

$864

Brand : BIOFRON
Catalogue Number : BN-O0023
Specification : 98%(HPLC)
CAS number : 652-78-8
Formula : C21H20O13
Molecular Weight : 480.4
PUBCHEM ID : 5281621
Volume : 10mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-O0023

Analysis Method

Specification

98%(HPLC)

Storage

2-8°C

Molecular Weight

480.4

Appearance

Botanical Source

Structure Type

Category

SMILES

C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O)O

Synonyms

2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

IUPAC Name

2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one

Density

1.883 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

310.8ºC

Boiling Point

886ºC at 760 mmHg

Melting Point

229-230ºC

InChl

InChl Key

SJRXVLUZMMDCNG-KKPQBLLMSA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:652-78-8) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

30797018

Abstract

Universal HIV testing and treatment of infected children remain challenging in resource-limited settings (RLS), leading to undiagnosed children/adolescents and limited access to pediatric antiretroviral therapy (ART). Our objective was to evaluate the feasibility of active cases finding of HIV-infected children/adolescents by provider-initiated testing and counseling in a health facility.

KEYWORDS

CLP; Gossypin; HMGβ1; Lung injury; NF-κB; NLRP3.

Title

Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats

Author

Irfan Cinar 1, Busra Sirin 2, Pelin Aydin 3, Erdem Toktay 4, Elif Cadirci 2, Iclal Halici 5, Zekai Halici 6

Publish date

2019 Mar 15

PMID

30536456

Abstract

Gossypin is a flavone extracted from Hibiscus vitifolius, which has been reported to exhibit anti-inflammatory, antioxidant, and anticancer activities. However, the anticancer properties of gossypin and its molecular mechanism of action against gastric cancer have not been fully investigated. In the present study, we report that gossypin is an Aurora kinase A (AURKA) and RSK2 inhibitor that suppresses gastric cancer growth. Gossypin attenuated anchorage-dependent and anchorage-independent gastric cancer cell growth as well as cell migration. Based on the results of in vitro screening and cell-based assays, gossypin directly binds to and inhibits AURKA and RSK2 activities and their downstream signaling proteins. Gossypin decreased S phase and increased G2/M phase cell cycle arrest by reducing the expression of cyclin A2 and cyclin B1 and the phosphorylation of the CDC protein. Additionally, gossypin also induced intrinsic apoptosis by activating caspases and PARP and increasing the expression of cytochrome c. Our results demonstrate that gossypin is an AURKA and RSK2 inhibitor that could be useful for treating gastric cancer.

KEYWORDS

AURKA; RSK2; apoptosis; gastric cancer; gossypin.

Title

Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2

Author

Li Wang 1, Xiangyu Wang 1, Hanyong Chen 2, Xueyin Zu 1 3, Fayang Ma 1 3, Kangdong Liu 1 3 4 5, Ann M Bode 2, Zigang Dong 1 2 5, Dong Joon Kim 1

Publish date

2019 Mar;

PMID

28302561

Abstract

Aim: Gentamicin (GEN) is an aminoglycoside antibiotic employed in treatment of life-threatening gram-negative infections, but one of its major side effects is the induction of nephrotoxicity. Therefore, the aim of this work was to scrutinize the possible protective effect of gossypin against GEN-induced nephrotoxicity.

Method: Rats were randomly divided into four groups. First group served as a control, second group was injected with gossypin (10mg/kg, orally) for 7days, third group was injected with GEN (80mg/kg, i.p.) and the fourth group was co-treated with GEN and gossypin for 7days.

Key finding: GEN-treated group showed kidney dysfunction as proteinuria excretion rate, podocalyxin excretion rates, renal monocyte chemoattractant protein-1 (MCP-1), blood urea nitrogen (BUN) and plasma creatinine were significantly increased as well as tubular degeneration occur. The significant decrease in renal reduced glutathione (GSH) level, superoxide dismutase (SOD) and catalase (CAT) activities and an increase in thiobarbituric acid reactive substances (TBARs) level, indicated that GEN-induced nephrotoxicity through oxidative stress reactions. Also, GEN up-regulated both gene expression and renal levels of inflammatory cytokines TNF-α and IL-6. On the other hand, concurrent treatment of gossypin plus GEN protected kidney tissues against nephrotoxic effects of GEN through elevated levels of renal GSH, SOD and CAT activities while decreased in renal TBARs level. In addition, gossypin down-regulated gene expression and renal levels of inflammatory cytokines TNF-α and IL-6 induced by GEN.

Significance: This study revealed that gossypin exerts protection against nephrotoxicity induced by gentamicin via its antioxidant activity.

KEYWORDS

Antioxidant; Gentamicin; Gossypin; IL-6; Monocyte chemoattractant protein-1; Nephrotoxicity; TNF-伪.

Title

Ameliorative effect of gossypin against gentamicin-induced nephrotoxicity in rats

Author

Mohamed Katary 1, Ahmad Salahuddin 2

Publish date

2017 May 1;